Nebula Research & Development’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,329
Closed -$696K 549
2025
Q2
$696K Buy
+3,329
New +$641K 0.06% 531
2025
Q1
Sell
-1,882
Closed -$425K 1077
2024
Q4
$425K Sell
1,882
-1,031
-35% -$230K 0.05% 615
2024
Q3
$607K Buy
+2,913
New +$586K 0.07% 483
2023
Q3
Sell
-3,352
Closed -$630K 601
2023
Q2
$630K Buy
3,352
+1,710
+104% +$323K 0.48% 10
2023
Q1
$320K Buy
+1,642
New +$306K 0.57% 69

Other funds holding MSGS

Nebula Research & Development's MSGS Position: Q3 2025 in Review

Nebula Research & Development sold out of Madison Square Garden (MSGS) in Q3 2025, closing a stake of 3,329 shares — an estimated $696K sold.

Nebula Research & Development first reported a position in MSGS in Q1 2023 and held it in 5 quarters. The position peaked at $696K in Q2 2025. 359 funds tracked by Wall St. Rank hold MSGS as of Q3 2025.

  • Nebula Research & Development reported no remaining Madison Square Garden position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 3,329 Madison Square Garden shares in Q3 2025, an estimated $696K.
  • Nebula Research & Development first reported a position in Madison Square Garden in Q1 2023 and held it in 5 quarters.
  • Nebula Research & Development's Madison Square Garden position peaked at $696K in Q2 2025.
  • 359 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.